Global Brand Manager ILARIS - ultra orphan & orphan rare disease indications @ Novartis Pharma AG
Consultant: Global Marketing Leadership - XOFLUZA (influenza) @ Roche
Consultant: Global Brand Management - specialty & rare diseases @ Roche
A career in pharmaceuticals spanning 19 years, achieving great success in sales (5 years), local marketing (5 years), and 9 years of international / global positions based in Switzerland for Novartis and then Shire. My global responsibilities have focused on success through strategic thinking which is taken through to local execution in close partnership with local affiliates,
A career in pharmaceuticals spanning 19 years, achieving great success in sales (5 years), local marketing (5 years), and 9 years of international / global positions based in Switzerland for Novartis and then Shire. My global responsibilities have focused on success through strategic thinking which is taken through to local execution in close partnership with local affiliates, regions and distributors. Experience includes:
Launch experience: in rare / orphan indications plus broader indications
Rare disease experience (6+ years): with biologics in immunology, Fabry, Gaucher, Hunter & HAE
Regional marketing leadership: EU, EMEA, LATAM and CEEMEA
Strategic leadership: bringing creative thinking to project leadership and execution
Cross-functional team leadership: leading cross-functional teams to success, through relationship-building and creation of a dynamic work environment
IPM Neuroscience & Rare Diseases a.i. @ From September 2015 to Present (4 months) Independent Consultant @ From March 2015 to August 2015 (6 months) Global Marketing Director, Rare Disease Brands, Central & Eastern Europe, Middle East & Africa @ Global brand director in rare disease (Hunter syndrome), with additional leadership of the marketing of all Shire rare disease brands (Replagal - Fabry, VPRIV - Gaucher, Elaprase - Hunter, Firazyr & Cinryze - HAE) for the CEEMEA region.
Responsibilities included: strategic planning, launch planning, patient-finding initiatives, disease awareness activities, performance tracking, key customer interaction, cross-functional leadership and very close partnership with local markets, sub-regional teams and distributor partners. From January 2014 to January 2015 (1 year 1 month) Associate Director Global Marketing REPLAGAL @ Leadership of Replagal Global Commercial Team (top 10 markets). Strategic planning, tactical implementation, sharing of best practice and exposure of broader headquarters-based cross-functional global team to local markets.
Key stakeholder management - building strong KOL relationships,leading cross-functional customer groups (advisory boards, patient-finding steering group).
Cross-functional team leadership: new campaign development, digital innovation in developing the company's first-ever "built for iPad" global sales aid platform. From February 2012 to December 2013 (1 year 11 months) EMEA Associate Brand Director Replagal @ Responsible for Replagal in EMEA region - contributing 65% of global brand revenue.
Led Replagal EMEA cross-functional team activities, and led the EMEA Commercial Team activities.
Introduced reforms to brand communications / messaging and roll-out processes.
Managed significant supply chain demands during competitor stock outage. From February 2011 to April 2012 (1 year 3 months) Global Brand Manager ILARIS (canakinumab) @ Ultra-orphan disease experience with Ilaris (canakinumab) - Novartis's first 'home-grown' biologic, with 3 indications launches planned in quick succession:
CAPS (Cryopyrin Associated Periodic Syndrome) - ultra orphan disease
SJIA (Systemic Juvenile Idiopathic Arthritis) - orphan disease
Gout / gouty arthritis - niche population in broader indication
Closely working with countries to ensure optimal launches utilising innovative launch model.
Development of risk management materials.
Created innovative online KOL community.
Partnered with patient association to develop multi-lingual online patient forum.
Commercial lead on development of future devices (pre-filled syringe & autoinjectors). From January 2009 to March 2011 (2 years 3 months) Global Brand Manager Lucentis @ Member of Lucentis (ophthalmics) brand team during launch phase. Budget management, digital activities, interaction with patient organisations. From July 2008 to December 2008 (6 months) Commercial Operations @ Strategic planning: worked with global brand teams across brands launching in CV, diabetes, respiratory, neuroscience & bone to help optimise crucial brand launches
Packaging redesign: a major cross-functional programme including stakeholders across corporate, branding, IP protection, trademarks and marketing
Advertising agency management: worked with global agency network partners to ensure branding alignment, creating synergies leading to aligned branded campaigns and significant cost savings across European markets. From October 2006 to July 2008 (1 year 10 months) Senior Product Manager HRT, UK & Ireland @ Commercial leadership of Hormone Replacement Therapy (HRT) franchise of 9 brands, focusing on Livial® (tibolone) across UK & Ireland.
Cross-functional leadership, strategic planning, introduced the initiative of the team of field-based brand 'champions'.
Crisis management during HRT 'breast cancer scare' - development of materials, KOL interaction, PR activities. From October 2004 to October 2006 (2 years 1 month) Product Manager Zispin & Zispin SolTab (CNS), UK & Ireland @ UK marketing of Zispin®, an antidepressant.
Introduction of new formulation, Zispin Soltab, in tight timelines due to impending patent loss.
In-licencing of migraine treatment Almogran® (almotriptan). From June 2003 to October 2004 (1 year 5 months) Product Manager, Hormone Replacement Therapy, UK & Ireland @ Led UK & Ireland operational marketing of Livial (HRT) and estradiol implants (HRT).
Device development for hormone implants.
KOL programme development.
Agency management. From March 2002 to June 2003 (1 year 4 months) Associate Product Manager, Hormone Replacement Therapy,UK & Ireland @ HRT - Livial and oestradiol implants.
Scientific expert meetings.
Promotional materials development. From December 2000 to March 2002 (1 year 4 months) Medical Sales Representative @ Women's health:
Implanon (contraceptive implant) launch
Marvelon and Mercilon (contraception) From November 1998 to December 2000 (2 years 2 months) Territory Business Manager, Cardiovascular & CNS @ Cardiovascular - primary product ZESTRIL (ACE inhibitor). Primary and Secondary care.
Migraine - launch of Zomig From August 1997 to November 1998 (1 year 4 months) Medical Sales Representative @ Cardiovascular, palliative care, epilepsy, acute pain management From November 1995 to August 1997 (1 year 10 months)
Bachelor of Science (BSc), Environmental Geology @ Royal Holloway, U. of London From 1991 to 1994 Gareth Davies is skilled in: Marketing, Rare diseases, Pharmaceutical Industry, Global Marketing, Pharmaceutical Sales, Sales Operations, Market Access, Leadership, Product Launch, Oncology, Sales Effectiveness, Healthcare, Biotechnology, Neurology, Rheumatology
Looking for a different
Get an email address for anyone on LinkedIn with the ContactOut Chrome extension